NAD+ for Fertility: Mechanism, Evidence, and Context

Last reviewed: May 12, 2026 Last updated: May 12, 2026

Written by: Jay Hastings , CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

Part of the PlexusDx Education Hub, covering longevity compounds, peptide biology, and the genetic variables behind aging-related decisions. Browse the full Peptides & Longevity library.

NAD+ turns up in fertility conversations because reproductive biology is energy-hungry and NAD+ is central to cellular energy metabolism. That connection makes the topic worth exploring carefully rather than sensationally. This piece explains what NAD+ is, how it works at the cellular level, what the evidence does and does not support, and the upstream genetic context, without overstating a role that the literature keeps measured.

Why NAD+ enters the fertility conversation

The link is mechanistic interest, not a promise. NAD+ is a coenzyme discussed across the longevity and wellness space, and because it participates in energy metabolism and cellular maintenance, it gets raised in discussions about reproductive aging. Framing matters here: this is a topic people research, and the responsible approach is to describe the biology and the limits of the evidence rather than imply an outcome.

What NAD+ is

NAD+ is a coenzyme found in every cell, widely discussed in the longevity-protocol space. It is offered in several formats, and the specifics of formulation and pricing appear on the relevant product page. As a compound, it is defined by its role in the cell rather than by any single indication, which is why it shows up across so many different wellness conversations.

How NAD+ works in cells

NAD+ acts on longevity-related biology through established enzymatic pathways. Its effects on energy metabolism, antioxidant defense, and cellular maintenance are mediated by the enzymes that depend on it as a cofactor. The pharmacological mechanism is well described in peer-reviewed literature, while clinical effect sizes vary by context, dose, individual factors, and adherence. Mechanism is clearer than any specific reproductive claim.

What the evidence does and does not say

This is where restraint is essential. The general biology of NAD+ is well characterized, but that does not translate into established fertility outcomes, and expectations should be calibrated to clinical literature rather than testimonials. Anyone considering NAD+ in the context of fertility should treat it as a provider conversation, weighing individual factors and concurrent care rather than assuming a benefit the evidence has not settled.

Where to start with PlexusDx

PlexusDx keeps its focus upstream of any compound decision. You can review the Longevity Protocols collection for what is offered and begin with the Precision Peptide Genetic Test to understand the biology before committing to a protocol. That sequence, biology first, keeps a fertility-adjacent decision grounded in your own physiology.

The genes shaping longevity biology

Underneath any longevity compound sits a consistent genetic layer. Variants in FOXO3, SIRT1, and KLOTHO influence the longevity-related pathways NAD+ acts through. These are pathway-level traits; they do not predict response to a specific compound, and the test is not pharmacogenomic. The Precision Peptide Genetic Test reads them across 14 pathways, 49 peptides, 150+ genetic insights, describing the terrain a clinician works within rather than forecasting any result.

Holding curiosity and caution together

Topics like NAD+ and fertility sit in a space where genuine scientific interest and overstated marketing often blur, so holding both curiosity and caution at once is the healthiest stance. The coenzyme biology is real and well characterized; the leap to a specific reproductive outcome is where the evidence thins. Keeping those two things distinct lets you explore the topic without being swept into claims the literature has not established. A provider conversation, informed by your individual factors and any concurrent care, is where that nuance belongs. Understanding your own longevity-pathway biology adds context to that discussion rather than a promise. The goal is an informed question for your clinician, not a conclusion drawn from a search result. Approaching an emerging topic this way, taking the biology seriously while resisting the pull of overstated claims, is what lets you learn from the science without being misled by the marketing that surrounds it.

Frequently Asked Questions

What is NAD+?

NAD+ is a coenzyme present in every cell and widely discussed in the longevity-protocol space for its role in energy metabolism and cellular maintenance. It is offered in several formats, with mechanism, formulation, and pricing detailed on the relevant product page. Expectations should track clinical literature rather than anecdote.

How does NAD+ work in the body?

NAD+ acts as a cofactor for enzymes involved in energy metabolism, antioxidant defense, and cellular repair, so its effects are mediated through those established pathways. The pharmacology is well described in peer-reviewed literature, while specific effects depend on dose, format, individual factors, and concurrent interventions.

Is NAD+ safe to consider?

NAD+ has a documented safety profile in the clinical literature, though common effects, warnings, and contraindications depend on the format and individual. Discuss your specific medical history with a prescribing provider. Compounded products from licensed 503A pharmacies follow USP standards for sterility and potency.

Does the genetic test predict a fertility outcome?

No. The Precision Peptide Genetic Test does not predict response to NAD+ or any compound and is not pharmacogenomic. It analyzes pathway-level variants in FOXO3, SIRT1, and KLOTHO that shape baseline longevity biology, providing upstream educational context rather than any reproductive forecast.

Keep reading across the PlexusDx Education Hub. Return to the education library.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.